|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
A method for treating a condition.
|
|
gptkbp:applicationNumber
|
09/123,456
|
|
gptkbp:applicationType
|
non-provisional
|
|
gptkbp:assignee
|
gptkb:ABC_Corporation
|
|
gptkbp:citedBy
|
gptkb:US_630000000_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:description
|
This patent describes a novel compound.
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
2020-05-01
|
|
gptkbp:fieldOfInvention
|
Pharmaceuticals
|
|
gptkbp:filingDate
|
2000-05-01
|
|
gptkbp:firstClaim
|
A method of treatment.
A method of synthesis.
A dosage form.
A compound of formula X.
A method of using the compound.
A pharmaceutical composition.
A kit.
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 620000000 B1
|
|
gptkbp:internationalClassification
|
C07D 401/12
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issueDate
|
2001-03-20
|
|
gptkbp:issuedBy
|
gptkb:United_States_Patent_and_Trademark_Office
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:ninthClaim
|
A method of administration.
A use of the compound.
A combination therapy.
|
|
gptkbp:patentClassification
|
A61K
A61K 31/00
|
|
gptkbp:patentFamily
|
US_620000000_B1,_US_630000000_B2
|
|
gptkbp:patentType
|
utility
|
|
gptkbp:priorityDate
|
1999-05-01
|
|
gptkbp:relatedTo
|
gptkb:US_610000000_A1
|
|
gptkbp:status
|
active
|